Community Regional Medical Center
Fresno, California, 93701, United States
NCT Number: NCT01431885
Use of modern diagnostic tools e.g. fetal fibronectin and ultrasound measurement of cervical length to diagnose preterm labor can result in improved outcomes compared to traditional diagnosis based on digital examination to measure cervical change.
Looking for future studies?
Notify Me16 year and older
Female
Interventional
Not applicable
Fresno, California, 93701, United States
Symptomatic preterm labor patients will be randomized to diagnosis of preterm labor by serial digital examination versus an algorithm incorporating transvaginal ultrasound measurement of cervical length and vaginal fetal fibronectin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diagnosis will be made by MOD Algorithm B
Other names: March of Dimes Preterm Labor Assessment Toolkit Algorithm B
Diagnosis will be made by digital examination of cervical change
Other names: None applicable
Time frame: No longer than 18 weeks post randomization (at which time a pregnancy randomized at the earliest possible gestational age would be 42 weeks, generally the contemporary upper limit of the duration of pregnancy)
Delivery of the baby prior to 37 weeks' gestation by any means and for any reason including spontaneous or indicated delivery for maternal or fetal complications
University of California, San Francisco
Other
Randomized Controlled Trial of Two Methods of Diagnosing Preterm Labor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03608995
Biomarkers, Female Urogenital Diseases and Pregnancy Complications
Clermont-Ferrand, France
View Trial DetailsNCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial DetailsNCT02511574
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
São Paulo, Brazil
View Trial DetailsNCT04831086
Amniocentesis Affecting Fetus or Newborn, Female Urogenital Diseases and Pregnancy Complications
Barcelona, Spain
View Trial Details